[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"424 General Military Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":40},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":19,"enrollmentInfo":20,"targetDuration":4,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100528747","sequential-therapies-after-osteoanabolic-treatment-100528747",false,"NCT06164795","Sequential Therapies After Osteoanabolic Treatment","Efficacy of Sequential Therapies After Osteoanabolic Treatment in Postmenopausal Women With Severe Osteoporosis: the Sequential Treatment After Romosozumab and Teriparatide\u002FAbaloparatide (START) Study","START","Inclusion Criteria:\n\n• Postmenopausal women treated with severe osteoporosis completing their course with romosozumab or teriparatide\n\nExclusion Criteria:\n\n* a bone disease other than postmenopausal osteoporosis\n* use of medications other than romosozumab or teriparatide affecting bone metabolism during the last 12 months before entering the study\n* creatinine clearance \\\u003C60 mL\u002Fmin\u002F1.73 m2\n* liver failure\n* any type of cancer\n* uncontrolled endocrine diseases\n* serum 25-hydroxy vitamin D (25-OHD) concentrations lower than 20 ng\u002FmL (50 nmol\u002FL)\n* hypersensitivity to denosumab or zoledronate or teriparatide or romosozumab or any of the excipients","FEMALE","50 Years","85 Years",{"count":21,"type":22},150,"ESTIMATED","OBSERVATIONAL","12-month prospective, open-label, multicenter, international, observational study evaluating sequential treatments after osteoanabolics",[26],"Osteoporosis, Postmenopausal","RECRUITING","2026-07-21",{"date":30,"type":31},"2026-07-22","ACTUAL",{"date":33,"type":31},"2023-11-25",{"date":35,"type":22},"2027-12",{"name":37,"class":38},"424 General Military Hospital","OTHER",8,""]